Allameh Farzad, Kazemi Mahsa, Ajorlou Mehrnaz, Soroush Saeed, Narouie Behzad, Fatemi Alireza, Dadpour Mehdi
Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Infertility and IVF Center, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Fertil Steril. 2023 Oct 1;17(4):259-263. doi: 10.22074/ijfs.2023.556335.1322.
During the Coronavirus disease 2019 (COVID-19) pandemic, there was always concern about damage to different organs of the body. In this study, we aimed to determine if coronavirus 2 (SARS-CoV-2) could influence the sperm parameters in inpatient adult men with COVID-19.
In this prospective study during 2021, 22 patients with COVID-19 diagnosed with polymerase chain reaction (PCR) test and clinical symptoms and history of admission and 19 volunteer healthy men as the control group participated. They were asked to provide semen samples at 2 and 6 months after hospital discharge and the same time for the control group. The following parameters were measured in all semen samples and beside the demographic data, they compared between the two groups: volume (mL), sperm concentration (10/mL), total motile sperm percentage, progressive percentage, normal morphology percentage, and DNA fragmentation index (DFI).
The mean ± SD age of the participants in the COVID and control groups was 46.36 ± 9.94 and 45.84 ± 10.21 years, respectively (P=0.869). The mean ± SD body mass index (BMIs) of the participants in the COVID and control groups were 28.6 ± 5.460 and 29.6 ± 6.092, respectively (P=0.579). The mean ± SD number of children was 1.41 ± 1.054 in the COVID group and 1.47 ± 1.073 in the control group (P=0.847). All the sperm parameters were significantly impaired after 2 months in the COVID group in comparison with the control group (P<0.05). After 4 months from first sampling, all the parameters were improved significantly (except normal morphology) but had not yet reached the level of the control group.
SARS-CoV-2 affected semen parameters in patients admitted because of COVID-19, in the short term. It is expected that this will improve with time.
在2019年冠状病毒病(COVID-19)大流行期间,人们一直担心身体不同器官会受到损害。在本研究中,我们旨在确定新型冠状病毒2(SARS-CoV-2)是否会影响COVID-19成年住院男性的精子参数。
在这项2021年进行的前瞻性研究中,22例经聚合酶链反应(PCR)检测及临床症状和入院史确诊为COVID-19的患者以及19名志愿健康男性作为对照组参与研究。要求他们在出院后2个月和6个月时提供精液样本,对照组在相同时间提供样本。在所有精液样本中测量以下参数,并除人口统计学数据外,对两组进行比较:体积(mL)、精子浓度(10/mL)、总活动精子百分比、进行性百分比、正常形态百分比和DNA碎片化指数(DFI)。
COVID组和对照组参与者的平均±标准差年龄分别为46.36±9.94岁和45.84±10.21岁(P = 0.869)。COVID组和对照组参与者的平均±标准差体重指数(BMI)分别为28.6±5.460和29.6±6.092(P = 0.579)。COVID组的平均±标准差子女数为1.41±1.054,对照组为1.47±1.073(P = 0.847)。与对照组相比,COVID组在2个月后所有精子参数均显著受损(P<0.05)。从首次采样4个月后,所有参数均显著改善(正常形态除外),但尚未达到对照组水平。
SARS-CoV-2在短期内影响了因COVID-19入院患者的精液参数。预计随着时间推移情况会有所改善。